Department of Medicine, Division of Cardiology, London Health Sciences Centre, The University of Western Ontario, London, Ontario, Canada.
Int J Cardiol. 2011 Feb 3;146(3):311-8. doi: 10.1016/j.ijcard.2010.08.010. Epub 2010 Sep 6.
Ischemic preconditioning is a natural protective mechanism by which brief episodes of ischemia protect the heart or other organs from the deleterious effects of ischemia-reperfusion injury. Ischemic preconditioning was demonstrated in animals more than 20 years ago, and subsequent studies in humans showed a dramatic protective effect on the heart. This method did not translate into clinical practice partially due to difficulty in application of conditioning. At the same time, multiple drugs were assessed, but none proved to be beneficial in large scale studies for myocardial protection. Although multicenter studies are still lacking, it was recently demonstrated in reasonable sized studies that in patients undergoing percutaneous coronary interventions or suffering from myocardial infarction, remote ischemic conditioning has beneficial protective effect. With more studies we may see translation into clinical practice in the near future.
缺血预处理是一种天然的保护机制,短暂的缺血发作可保护心脏或其他器官免受缺血再灌注损伤的有害影响。缺血预处理在 20 多年前在动物身上得到证实,随后在人类中的研究显示对心脏有显著的保护作用。这种方法部分由于难以实施预处理而没有转化为临床实践。同时,评估了多种药物,但没有一种药物在大规模的心肌保护研究中被证明是有益的。尽管多中心研究仍然缺乏,但最近在合理规模的研究中证明,在接受经皮冠状动脉介入治疗或患有心肌梗死的患者中,远程缺血预处理具有有益的保护作用。随着更多的研究,我们可能会在不久的将来看到它转化为临床实践。